Link address : http://www.prnewswire.com/news-releases/sillajen-announces-agreement-with-the-fda-for-a-special-protocol-assessment-for-upcoming-phase-3-pexa-vec-trial-in-advanced-liver-cancer-300066952.html
Targeting, Attacking, and Eradicating Cancers®
